SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-135161
Filing Date
2024-05-09
Accepted
2024-05-09 14:41:37
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-1/A d827405ds1a.htm S-1/A 88892
2 EX-5.1 d827405dex51.htm EX-5.1 18459
3 GRAPHIC g827405g0509220548439.jpg GRAPHIC 4024
4 GRAPHIC g827405g25u10.jpg GRAPHIC 2934
  Complete submission text file 0001193125-24-135161.txt   118260
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278844 | Film No.: 24929959
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)